Altium Capital Management LLC

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Altium Capital Management LLC reported 46 stock positions worth $222.3 million. Its top holding was Vera Therapeutics (VERA) at 13.8% of the portfolio, followed by Xenon Pharmaceuticals (XENE, 6.7%) and Axsome Therapeutics (AXSM, 5.0%). Compared with Q4 2023, it opened 24 new positions, sold out of 18, added to 11 and reduced 6. The biggest buy was Vera Therapeutics (VERA, shares +15%) and the biggest sale an exit from Alpha Architect 1-3 MNTH Box (BOXX).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001746382
Portfolio Value
$222.3M (Q1 2024)
SEC Filing
0001420506-24-000943 ↗ filed May 15, 2024

Holdings Value

0$100.0M$200.0M$300.0M$400.0M Q1 2024: $222.3M $222.3M Q1 2024 Q2 2024: $241.2M Q2 2024 Q3 2024: $334.9M Q3 2024 Q4 2024: $321.1M Q4 2024 Q1 2025: $34.4M Q1 2025 Q2 2025: $0 Q2 2025 Q3 2025: $628K Q3 2025 Q4 2025: $25.3M Q4 2025 Q1 2026: $42.0M Q1 2026 Q2 2026: $47.5M Q2 2026

Holdings 46 stocks · $222.3M
VERA Vera Therapeutics Inc. 13.77% 710,000 $30.6M Add +15.4%
XENE Xenon Pharmaceuticals Inc. 6.74% 348,000 $15.0M Add +19.8%
AXSM Axsome Therapeutics Inc. 4.95% 138,000 $11.0M No change
ADMA Adma Biologics Inc. 4.57% 1,540,000 $10.2M Add +40.6%
ALIM Alimera Sciences Inc. 4.47% 2,550,000 $9.9M Reduce -4.1%
AVDL Avadel Pharmaceuticals plc 4.20% 553,057 $9.3M New
XTNT Xtant Medical Holdings Inc. 4.03% 7,647,873 $8.9M Reduce -4.7%
CPRX Catalyst Pharmaceuticals Inc. 3.59% 500,000 $8.0M Add +29.9%
ITCI Intra-Cellular Therapies Inc. 3.52% 113,000 $7.8M Add +59.1%
BHVN Biohaven Ltd. 3.44% 140,000 $7.7M New
VKTX Viking Therapeutics Inc. 3.14% 85,000 $7.0M New
OLMA Olema Pharmaceuticals Inc. 3.08% 605,000 $6.8M Add +46.3%
SVRA Savara Inc. 2.99% 1,335,000 $6.6M Add +0.1%
SLNO Soleno Therapeutics Inc. 2.94% 152,909 $6.5M Add +45.8%
CYBIN INC 2.60% 13,953,488 $5.8M New
ORIC Oric Pharmaceuticals Inc. 2.51% 405,000 $5.6M Reduce -40.1%
LRMR Larimar Therapeutics Inc. 2.37% 695,000 $5.3M New
MIRM Mirum Pharmaceuticals Inc. 2.35% 208,000 $5.2M New
NGNE Neurogene Inc. 2.29% 100,000 $5.1M Add +49.3%
PRAX Praxis Precision Medicines I 2.14% 78,100 $4.8M New
ACHV Achieve Life Sciences Inc. 1.71% 835,470 $3.8M New
ASND Ascendis Pharma A/S 1.70% 25,000 $3.8M No change
LBPH Longboard Pharmaceuticals Inc. 1.65% 170,000 $3.7M New
INSM Insmed Inc. 1.46% 120,000 $3.3M No change
REAL The Realreal Inc. filed as THE REALREAL INC 1.41% 800,000 $3.1M New
ALPN Alpine Immune Sciences Inc. 1.39% 77,848 $3.1M Reduce -1.1%
BOLD Boundless Bio Inc. 1.28% 200,000 $2.9M New
AQST Aquestive Therapeutics Inc. 1.27% 665,000 $2.8M New
RYTM Rhythm Pharmaceuticals Inc. 1.12% 57,271 $2.5M Add +783.1%
MIST Milestone Pharmaceuticals Inc. 0.98% 1,212,882 $2.2M New
ATXS Astria Therapeutics Inc. 0.90% 142,532 $2.0M Reduce -80.5%
ZVRA Zevra Therapeutics Inc. 0.89% 341,461 $2.0M New
MRNS Marinus Pharmaceuticals Inc. 0.72% 176,840 $1.6M Reduce -11.6%
BIOVIE INC 0.72% 3,012,608 $1.6M New
TRML Tourmaline Bio Inc. 0.67% 65,442 $1.5M New
VERU Veru Inc. 0.67% 2,111,731 $1.5M Add +5.6%
KPTI Karyopharm Therapeutics Inc. 0.50% 740,000 $1.1M No change
SPRB Spruce Biosciences Inc. 0.41% 1,150,000 $904K New
CATX Perspective Therapeutics Inc. 0.29% 535,657 $637K New
EVOK Evoke Pharma Inc. 0.20% 724,942 $442K New
PMNT Perfect Moment Ltd. 0.15% 92,208 $330K New
MOBILICOM LTD 0.07% 135,292 $161K New
GRI BIO INC 0.06% 187,981 $143K New
AZITRA INC 0.05% 493,153 $101K New
QUOIN PHARMACEUTICALS LTD 0.03% 66,240 $63K New
VSEEW Digital Health Acquisition C 0.01% 150,000 $19K No change

Options reported separately and not counted above: VIKING THERAPEUTICS INC puts ($14.4M), ADVISORSHARES TR calls ($11.3M), RAPT THERAPEUTICS INC calls ($1.8M), GERON CORP calls ($1.3M).

Other holdings (22): bonds, preferreds, convertibles and warrants · $1.6M (not counted above)
SecurityClassShares / PrincipalValueChange
FATBW Fat Brands Inc. -CW25 *W EXP 07/16/202 200,000$974KNo change
RCKTW Rocket Pharmaceuticals in-27 *W EXP 09/02/202 731,561$219KNew
NXGLW Nexgel Inc. -CW26 *W EXP 12/27/202 225,000$162KNo change
WLDSW Wearable Devices Ltd. - 27 *W EXP 09/14/202 1,411,600$109KNo change
MBTCR Nocturne Acquisition-Rights RIGHT 12/26/2025 500,000$82KNo change
MOBXW Chavrant Capital Acq -CW23 *W EXP 12/21/202 150,000$32KNo change
ONFOW Onfolio Holdings Inc. -27 *W EXP 01/02/202 200,000$8KNo change
NLSPW NLS Pharmaceutics Ltd. -CW25 *W EXP 02/02/202 200,000$7KNo change
CDTTW Murphy Canyon Acq-CW27 *W EXP 09/22/202 100,000$6KNo change
CINGW Cingulate -CW23 *W EXP 12/10/202 270,000$6KNo change
BTMWQ Bitcoin Depot Inc.-CW23 *W EXP 06/30/202 50,000$5KNo change
NXLIW Nexalin Technology Inc.- 27 *W EXP 99/99/999 105,000$4KNo change
CYCUW Cycurion Inc.-CW27 *W EXP 02/13/203 100,000$4KNo change
NEXRW Jeffs Brands Ltd. -27 *W EXP 08/26/202 68,681$4KNo change
SRZNW Surrozen Inc.-CW25 *W EXP 08/01/203 82,233$3KNo change
BNCWW Cea Industries Inc. -CW27 *W EXP 02/11/202 250,000$3KNo change
OSPWQ Prosomnus Inc.-CW27 *W EXP 04/20/202 150,000$3KNo change
MITAW Coliseum Acquisition A -CW28 *W EXP 08/22/202 28,333$2KNo change
SLNWF Selina Hospitality PLC-27 *W EXP 10/27/202 101,439$710No change
TCBWF TC Biopharm Holdings Ltd. *W EXP 02/10/202 18,823$376No change
BRSWF Bruush Oral Care Inc. -27 *W EXP 08/03/202 14,423$110No change
RACYW Relativity Acquisition-CW27 *W EXP 12/15/202 100,000$0No change

Total filed on the 13F, all lines: $223.9M.

Portfolio Sells Q4 2023 → Q1 2024
BOXX Alpha Architect 1-3 MNTH Box Sold out 0.00% −6.77
ALIM Alimera Sciences Inc. Reduce -4.1% 4.47% −3.50
ATXS Astria Therapeutics Inc. Reduce -80.5% 0.90% −2.99
IMVT Immunovant Inc. Sold out 0.00% −2.34
XTNT Xtant Medical Holdings Inc. Reduce -4.7% 4.03% −2.27
CBAY Cymabay Therapeutics Inc. Sold out 0.00% −1.82
ORIC Oric Pharmaceuticals Inc. Reduce -40.1% 2.51% −1.81
SGMT Sagimet Biosciences Inc. Class A Sold out 0.00% −1.76
CRNX Crinetics Pharmaceuticals Inc. Sold out 0.00% −1.61
NVNO Envveno Medical Corporation Sold out 0.00% −1.23
AMLX Amylyx Pharmaceuticals Inc. Sold out 0.00% −1.22
CYTK Cytokinetics Inc. Sold out 0.00% −1.16
ARVN Arvinas Inc. Sold out 0.00% −0.89
FBIO Fortress Biotech Inc. Sold out 0.00% −0.85
MRNS Marinus Pharmaceuticals Inc. Reduce -11.6% 0.72% −0.79
DMAC Diamedica Therapeutics Inc. Sold out 0.00% −0.57
MSOS Advisorshares Pure US Cann Sold out 0.00% −0.39
DDI Doubledown Interactive -ADR Sold out 0.00% −0.31
FLNA Filana Therapeutics Inc. Sold out 0.00% −0.20
TNXP Tonix Pharmaceuticals Holdin Sold out 0.00% −0.15
CYCLACEL PHARMACEUTICALS INC Sold out 0.00% −0.07
SADOT GROUP INC Sold out 0.00% −0.05
NOVABAY PHARMACEUTICALS INC Sold out 0.00% −0.01
ALPN Alpine Immune Sciences Inc. Reduce -1.1% 1.39% +0.35

Portfolio Buys Q4 2023 → Q1 2024
VERA Vera Therapeutics Inc. Add +15.4% 13.77% +7.21
AVDL Avadel Pharmaceuticals plc New 4.20% +4.20
BHVN Biohaven Ltd. New 3.44% +3.44
VKTX Viking Therapeutics Inc. New 3.14% +3.14
CYBIN INC New 2.60% +2.60
LRMR Larimar Therapeutics Inc. New 2.37% +2.37
MIRM Mirum Pharmaceuticals Inc. New 2.35% +2.35
PRAX Praxis Precision Medicines I New 2.14% +2.14
ACHV Achieve Life Sciences Inc. New 1.71% +1.71
LBPH Longboard Pharmaceuticals Inc. New 1.65% +1.65
REAL The Realreal Inc. New 1.41% +1.41
NGNE Neurogene Inc. Add +49.3% 2.29% +1.39
BOLD Boundless Bio Inc. New 1.28% +1.28
AQST Aquestive Therapeutics Inc. New 1.27% +1.27
ADMA Adma Biologics Inc. Add +40.6% 4.57% +1.14
MIST Milestone Pharmaceuticals Inc. New 0.98% +0.98
RYTM Rhythm Pharmaceuticals Inc. Add +783.1% 1.12% +0.91
ZVRA Zevra Therapeutics Inc. New 0.89% +0.89
BIOVIE INC New 0.72% +0.72
TRML Tourmaline Bio Inc. New 0.67% +0.67
SPRB Spruce Biosciences Inc. New 0.41% +0.41
CATX Perspective Therapeutics Inc. New 0.29% +0.29
EVOK Evoke Pharma Inc. New 0.20% +0.20
PMNT Perfect Moment Ltd. New 0.15% +0.15
MOBILICOM LTD New 0.07% +0.07
GRI BIO INC New 0.06% +0.06
AZITRA INC New 0.05% +0.05
QUOIN PHARMACEUTICALS LTD New 0.03% +0.03
SLNO Soleno Therapeutics Inc. Add +45.8% 2.94% +0.01
ITCI Intra-Cellular Therapies Inc. Add +59.1% 3.52% −0.01
VERU Veru Inc. Add +5.6% 0.67% −0.33
CPRX Catalyst Pharmaceuticals Inc. Add +29.9% 3.59% −0.91
OLMA Olema Pharmaceuticals Inc. Add +46.3% 3.08% −0.95
SVRA Savara Inc. Add +0.1% 2.99% −1.36
XENE Xenon Pharmaceuticals Inc. Add +19.8% 6.74% −2.55

Options Activity Q4 2023 → Q1 2024
VIKING THERAPEUTICS INC put New 175,300 $14.4M
ADVISORSHARES TR call New 1,125,000 $11.3M
RAPT THERAPEUTICS INC call New 200,000 $1.8M
GERON CORP call New 400,000 $1.3M
CASSAVA SCIENCES INC put Sold out 47,000 $1.1Mbefore exit
ACURX PHARMACEUTICALS INC put Sold out 170,300 $652Kbefore exit
BIOXCEL THERAPEUTICS INC put Sold out 169,200 $499Kbefore exit

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

Notes & Other Activity Q4 2023 → Q1 2024
RCKTW Rocket Pharmaceuticals in-27 *W EXP 09/02/202 New 731,561 $219K
PEPLW Pepperlime Health Acq -CW23 *W EXP 10/01/202 Sold out 367,500 $11Kbefore exit
TGVCW TG Venture Acquisition -CW23 *W EXP 08/15/202 Sold out 200,000 $3Kbefore exit

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 19$47.5MRMT, ASA, RVT, NBXG, PDX
Q1 2026 19$42.0MPDX, ASA, RVT, XPCQX, GAM
Q4 2025 18$25.3MASA, RVT, PDX, NBXG, XPCQX
Q3 2025 1$628KCNSY
Q2 2025 0$0
Q1 2025Amended 22$34.4MZVRA, EOLS, XTNT, AVDL, CTNM
Q4 2024 61$321.1MADMA, VERA, SRPT, ZVRA, ESTA
Q3 2024 57$334.9MVERA, ADMA, SRPT, EW, XENE
Q2 2024 45$241.2MVERA, ADMA, XENE, ITCI, SRPT
Q1 2024 46$222.3MVERA, XENE, AXSM, ADMA, ALIM